Drug intelligence / Profile preview

crocin + selenium

Development stage
Unknown
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

Crocin + selenium is a **combination therapy** typically formulated as **nanoparticles** or physical mixtures intended for synergistic antioxidant and therapeutic effects. Crocin is a carotenoid compound found in saffron (*Crocus sativus*), known for its antioxidant, anti-inflammatory, neuroprotective, and anticancer properties, achieved by inhibiting monoamine oxidase (MAO) enzyme activity, blocking serotonin reuptake, modulating nuclear factor-kappa B pathway activity, and reducing pro-inflammatory cytokines[4]. Selenium, an essential trace element, functions pharmacologically as an antioxidant and immunomodulator by being incorporated into selenoproteins (including glutathione peroxidase and thioredoxin reductase), influencing oxidative stress, immune response, and cellular survival[5][6]. When combined, especially as crocin-conjugated selenium nanoparticles, the formulation shows enhanced efficacy in preclinical models for cancer via increased cytotoxicity and apoptosis induction, and in human studies has demonstrated improvement in cognitive impairment and antioxidant markers in multiple sclerosis patients[1][3]. Nanoparticle delivery (e.g., PEG-functionalized SeNPs) allows for targeted release, increased bioavailability, and reduction in side effects, establishing this combination as a promising approach for indications associated with oxidative stress or inflammation.

Other names
crocin-selenium nanoparticlesCor@SeNs
02

Targets

GPX4 (Glutathione peroxidase 4)GSR (Glutathione reductase)

Beyond the preview

Go deeper on crocin + selenium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on crocin + selenium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call